GW Pharmaceuticals Ret. on equity
What is the Ret. on equity of GW Pharmaceuticals?
The Ret. on equity of GW Pharmaceuticals is -9.54%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with ret. on equity similar to GW Pharmaceuticals
- Paltalk Inc has Ret. on equity of -9.58%
- Vinacapital Vietnam Opportunity Fund (United Kingdom) has Ret. on equity of -9.56%
- Sunwah Kingsway Capital has Ret. on equity of -9.56%
- Nuveen Preferred & Income Opportunities Fund has Ret. on equity of -9.56%
- PVR has Ret. on equity of -9.56%
- Chuang's Consortium International has Ret. on equity of -9.54%
- GW Pharmaceuticals has Ret. on equity of -9.54%
- Ascletis Pharma has Ret. on equity of -9.53%
- WAM Research has Ret. on equity of -9.53%
- Life Healthcare has Ret. on equity of -9.53%
- Ruhnn Ltd has Ret. on equity of -9.53%
- Yorbeau Resources has Ret. on equity of -9.53%
- MMJ PhytoTech has Ret. on equity of -9.52%